Five Reason Repros Therapeutics Is Hitting 52-Week Highs - trackseekingalpha

Sign Up | Log In | What is SocialPicks?

Five Reason Repros Therapeutics Is Hitting 52-Week Highs
Jan 09, 2009 01:17 PM UTC

trackseekingalpha

Return	Risk
-11.17%	HIGH

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
RPRX	n/a

Via Long Investment Ideas from Seeking Alpha:

Five reasons Repros Therapeutics (RPRX) is hitting 52-week highs:

1. Rare among biotechs, its funding needs have been met. Last year, Repros agreed with Efficacy Capital to allow the fund to buy up to 40 percent of the outstanding shares. Despite the credit crunch, Efficacy infused $15 million to the firm and agreed to buy more should RPRX need it. The agreement is here.

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.